Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
British Journal of Cancer
|
July 1, 2017
Embracing model-based designs for dose-finding trials
Sharon B Love, Sarah Brown, Christopher J Weir, et al.
Haematologica
|
June 1, 2005
Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial
Norbert Schmitz, Meral Beksac, Andrea Bacigalupo, et al.
Pharmaceutical Statistics
|
October 22, 2009
Missing data: discussion points from the PSI missing data expert group
Tomasz Burzykowski, James Carpenter, Corneel Coens, et al.
British Journal of Haematology
|
July 25, 2003
Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study
Michael Hedenus, Magnus Adriansson, Jesus San Miguel, et al.
Nature Reviews. Drug Discovery
|
January 20, 2018
Impact of a five-dimensional framework on R&D productivity at AstraZeneca
Paul Morgan, Dean G Brown, Simon Lennard, et al.
Annals of Neurology
|
January 24, 2006
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
Anthony E Lang, Steven Gill, Nik K Patel, et al.
BMJ (Clinical Research Ed.)
|
October 20, 2023
Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance
Christina Yap, Olga Solovyeva, Johann de Bono, et al.
BMJ (Clinical Research Ed.)
|
October 20, 2023
Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance
Christina Yap, Jan Rekowski, Moreno Ursino, et al.
Eclinicalmedicine
|
January 29, 2025
SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols
Moreno Ursino, Guillermo Villacampa, Jan Rekowski, et al.
Eclinicalmedicine
|
January 29, 2025
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials
Jan Rekowski, Christina Guo, Olga Solovyeva, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
British Journal of Cancer
|
July 1, 2017
Embracing model-based designs for dose-finding trials
Sharon B Love, Sarah Brown, Christopher J Weir, et al.
Haematologica
|
June 1, 2005
Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial
Norbert Schmitz, Meral Beksac, Andrea Bacigalupo, et al.
Pharmaceutical Statistics
|
October 22, 2009
Missing data: discussion points from the PSI missing data expert group
Tomasz Burzykowski, James Carpenter, Corneel Coens, et al.
British Journal of Haematology
|
July 25, 2003
Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study
Michael Hedenus, Magnus Adriansson, Jesus San Miguel, et al.
Nature Reviews. Drug Discovery
|
January 20, 2018
Impact of a five-dimensional framework on R&D productivity at AstraZeneca
Paul Morgan, Dean G Brown, Simon Lennard, et al.
Annals of Neurology
|
January 24, 2006
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
Anthony E Lang, Steven Gill, Nik K Patel, et al.
BMJ (Clinical Research Ed.)
|
October 20, 2023
Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance
Christina Yap, Olga Solovyeva, Johann de Bono, et al.
BMJ (Clinical Research Ed.)
|
October 20, 2023
Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance
Christina Yap, Jan Rekowski, Moreno Ursino, et al.
Eclinicalmedicine
|
January 29, 2025
SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols
Moreno Ursino, Guillermo Villacampa, Jan Rekowski, et al.
Eclinicalmedicine
|
January 29, 2025
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials
Jan Rekowski, Christina Guo, Olga Solovyeva, et al.
Page
of 2